ANDA 73696, held by Watson Labs. Nitrofurantoin, Macrocrystalline.
As of Nov 16, 2026, ANDA 73696 (Nitrofurantoin), held by Watson Labs, was first approved by FDA on Dec 31, 1992, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 31, 1992 | Original application | Approved | None posted |
| Nitrofurantoin25MG · capsule;oral | Nitrofurantoin, Macrocrystalline | Discontinued |
| Nitrofurantoin50MG · capsule;oral | Nitrofurantoin, Macrocrystalline | Discontinued |
| Nitrofurantoin100MG · capsule;oral | Nitrofurantoin, Macrocrystalline | Discontinued |
| Aug 30, 1999 | Supplement 5Labeling | Approved | None posted |
| Dec 1, 1998 | Supplement 3Labeling | Approved | None posted |
| Feb 12, 1998 | Supplement 2Labeling | Approved | None posted |
| Jan 8, 1997 | Supplement 1Labeling | Approved | None posted |
| Dec 31, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters